Want to see SE:ATT full AI Analyst Report?
Top Page
Attendo AB
(ATT)
Select Model
Select Model
Rating:63Neutral
Price Target:
kr131.00
▲(64.37% Upside)
Action:Reiterated
Date:05/09/26
The score is primarily driven by improving profitability and strong free-cash-flow generation, offset by elevated leverage and a major TTM revenue decline that raises near-term business quality concerns. Technicals are supportive with a clear uptrend and neutral momentum, while valuation is roughly mid-range with a low dividend yield.
Positive Factors
Strong free cash flow
Attendo's free cash flow generation has been consistently strong and closely tracks reported earnings (~85–94% of net income). Durable FCF supports debt servicing, reinvestment in facilities and operations, and gives financial flexibility versus peers despite cyclic pressures.
Negative Factors
High leverage
Leverage near ~2.9x equity is a persistent constraint, reducing financial flexibility in a rate-sensitive environment. Elevated debt limits ability to invest, pursue acquisitions, or absorb contract churn, and increases refinancing and interest-cost risk over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong free cash flow
Attendo's free cash flow generation has been consistently strong and closely tracks reported earnings (~85–94% of net income). Durable FCF supports debt servicing, reinvestment in facilities and operations, and gives financial flexibility versus peers despite cyclic pressures.
Read all positive factors
Attendo AB (ATT) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr18.49B
Dividend Yield1.47%
Average Volume (3M)307.31K
Price to Earnings (P/E)20.7
Beta (1Y)0.48
Revenue Growth-2.19%
EPS Growth76.78%
CountrySE
Employees33,000
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)5.93
Shares Outstanding151,196,120
10 Day Avg. Volume430,436
30 Day Avg. Volume307,315
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)2.24
Price to Sales (P/S)0.64
P/FCF Ratio4.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)6.64
Revenue Forecast (FY)kr18.92B
Attendo AB Business Overview & Revenue Model
Company Description
Founded in 1985 and based in Danderyd, Sweden, Attendo AB (publ) is a prominent provider of publicly financed care services across the Nordic countries, including Sweden, Finland, Norway, and Denmark. The company's extensive service portfolio addr...
How the Company Makes Money
Attendo makes money by delivering care services that are predominantly financed by the public sector. Its main revenue model is service provision under (1) municipal or regional procurement contracts/tenders and framework agreements, and/or (2) au...
Attendo AB Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
48
Neutral
Cash Flow
74
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.91B | 18.99B | 18.98B | 17.29B | 14.50B | 12.87B |
| Gross Profit | 3.08B | 3.20B | 8.20B | 5.92B | 1.52B | 1.42B |
| EBITDA | 3.95B | 3.87B | 3.44B | 3.05B | 2.18B | 1.99B |
| Net Income | 875.00M | 813.00M | 450.00M | 376.00M | -45.00M | 56.00M |
Balance Sheet | ||||||
| Total Assets | 24.39B | 25.05B | 25.24B | 22.89B | 22.32B | 21.08B |
| Cash, Cash Equivalents and Short-Term Investments | 733.00M | 1.27B | 821.00M | 922.00M | 507.00M | 513.00M |
| Total Debt | 15.83B | 16.44B | 16.74B | 14.75B | 14.80B | 13.88B |
| Total Liabilities | 18.93B | 19.60B | 19.91B | 17.53B | 17.32B | 16.12B |
| Stockholders Equity | 5.45B | 5.45B | 5.33B | 5.36B | 5.00B | 4.93B |
Cash Flow | ||||||
| Free Cash Flow | 2.80B | 2.65B | 2.26B | 2.08B | 1.13B | 1.21B |
| Operating Cash Flow | 2.99B | 2.85B | 2.46B | 2.23B | 1.33B | 1.38B |
| Investing Cash Flow | -196.00M | -330.00M | -1.24B | -185.00M | -390.00M | -413.00M |
| Financing Cash Flow | -2.53B | -2.04B | -1.33B | -1.63B | -970.00M | -1.18B |
Attendo AB Technical Analysis
Positive
79.70
Price Trends
110.61
Positive
105.84
Positive
91.63
Positive
Market Momentum
2.51
Negative
65.21
Neutral
91.02
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ATT, the sentiment is Positive. The current price of 79.7 is below the 20-day moving average (MA) of 114.06, below the 50-day MA of 110.61, and below the 200-day MA of 91.63, indicating a bullish trend. The MACD of 2.51 indicates Negative momentum. The RSI at 65.21 is Neutral, neither overbought nor oversold. The STOCH value of 91.02 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:ATT.
Attendo AB Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | kr1.62B | 30.82 | ― | ― | 3.23% | -63.00% | |
69 Neutral | kr7.91B | 34.94 | 15.16% | ― | 18.06% | 10.57% | |
68 Neutral | kr11.31B | 17.49 | 12.96% | 1.56% | 15.74% | 15.67% | |
63 Neutral | kr18.49B | 20.69 | ― | 1.47% | -2.19% | 76.78% | |
61 Neutral | kr1.57B | 67.06 | ― | ― | ― | ― | |
56 Neutral | kr3.10B | 15.97 | 7.53% | 2.01% | -4.47% | 6.10% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
SE:ATT
Attendo AB
122.70
61.14
99.31%
SE:HUM
Humana AB
64.50
28.58
79.54%
SE:AMBEA
Ambea AB
149.50
37.85
33.90%
SE:MCAP
MedCap AB
524.50
56.00
11.95%
SE:SUS
Surgical Science Sweden AB
31.74
-118.96
-78.94%
SE:CARA
Carasent AB
22.80
-6.85
-23.10%
Attendo AB Corporate Events
Attendo CEO Martin Tivéus to Step Down After Eight Years, Strategy Unchanged
Jun 30, 2026
Attendo AB, the Nordic region’s largest private care provider, operates a broad network of care units across Finland, Sweden and Denmark, with its headquarters in Stockholm and a listing on Nasdaq Stockholm. The company’s business mode...
Attendo Accelerates Share Buybacks Under SEK 275m Repurchase Program
Jun 30, 2026
Attendo AB has continued executing its board-approved share repurchase program, buying back 150,000 shares on Nasdaq Stockholm between 22 and 26 June 2026. The week’s transactions, carried out by DNB Carnegie Investment Bank, were valued at ...
Attendo Steps Up Share Buybacks Under SEK 275 Million Programme
Jun 23, 2026
Attendo AB has continued its share buyback programme, repurchasing 120,000 shares over the week of 15–19 June 2026 on Nasdaq Stockholm at an average price of about SEK 110.38 per share. The transactions, executed by DNB Carnegie Investment B...
Attendo to Bolster Southern Sweden Care Network with Skåningegård Acquisition
Jun 18, 2026
Attendo AB is the leading Nordic care provider, offering elderly care, disability services and social care through about 770 units and 33,000 employees in Finland, Sweden and Denmark. Listed on Nasdaq Stockholm and based in Stockholm, the group fo...
Attendo Steps Up Share Buybacks, Tightening Free Float
Jun 16, 2026
Attendo AB has continued to execute its share buyback programme, repurchasing 175,000 shares on Nasdaq Stockholm during the week of 8–12 June 2026 for roughly SEK 20 million. The company has now acquired a total of 905,000 shares under the c...
Attendo Invests in New Vallentuna Nursing Home to Meet Future Elderly Care Demand
Jun 10, 2026
Attendo is deepening its presence in Vallentuna, outside Stockholm, with a long-term investment in elderly care that includes relocating the Vårdbo nursing home to larger, refurbished premises in central Vallentuna. The new 3,500-square-metre...
Attendo Steps Up Share Buybacks as Treasury Holdings Grow
Jun 9, 2026
Nordic care provider Attendo AB has continued its share buyback program, repurchasing 170,000 shares on Nasdaq Stockholm between 1 and 5 June 2026 at an average price of about SEK 111.79, for a total value of roughly SEK 19 million. The program, e...
Attendo Advances SEK 275 Million Share Buyback as Treasury Stock Rises
Jun 2, 2026
Attendo AB has continued its share buyback programme, repurchasing 175,000 shares on Nasdaq Stockholm between 25 and 29 May 2026 for a total of about SEK 20.5 million, at an average price of SEK 117.43 per share. The transactions, executed by DNB ...
Attendo Streamlines Capital Structure With Cancellation of Treasury Shares
May 29, 2026
Attendo AB, the Nordic region’s largest private care provider with extensive elderly and social care operations in Finland, Sweden and Denmark, continues to expand its role as a key partner to the public sector in tackling structural care ch...
Attendo Shares Trade Steadily in Narrow Range on Nasdaq Stockholm
May 12, 2026
Attendo AB reported detailed intraday trading data for its shares on Nasdaq Stockholm on 7 May 2026, showing multiple transactions throughout the trading day in the price range of roughly SEK 105.70 to SEK 107.40. The pattern indicates steady liqu...
Attendo AGM Backs Dividend, New Incentive Plans and Capital Changes
May 6, 2026
Attendo AB’s Annual General Meeting re-elected Ulf Mattsson as chair of a six-member board and appointed PwC as auditor until 2027, while approving the 2025 financial statements, remuneration report and releasing the board and CEO from liabi...
Attendo Launches SEK 275 Million Share Buyback to Optimize Capital Structure
May 6, 2026
Attendo’s board has approved a share buyback program of up to SEK 275 million, aiming to optimize the company’s capital structure and provide shares for existing incentive programs for employees and management. The repurchases, which w...
Attendo’s Unika expands specialised Prader–Willi care with new Mölndal unit
May 6, 2026
Attendo’s Unika brand, which consolidates its Swedish LSS disability services, has opened a new specialised unit in Mölndal for people with Prader–Willi syndrome, a rare condition requiring highly adapted support. The residence is...
Attendo Boosts Profitability on Higher Occupancy Despite Sales Dip
May 6, 2026
Attendo reported continued positive development across its business areas in the first quarter of 2026, driven by higher occupancy and improved operational efficiency, which helped lift adjusted earnings per share to 6.47 SEK on a rolling 12‑...
Attendo crosses 5% threshold in ongoing share buyback programme
Apr 29, 2026
Attendo AB has disclosed that it repurchased 25,000 of its own shares on 28 April 2026, bringing its total holding of treasury shares to 7,569,713, or 5.01 percent of the company’s outstanding shares. Crossing the five percent threshold trig...
Attendo strengthens Finnish addiction care footprint with A-klinikka acquisition
Apr 28, 2026
Attendo Finland has agreed to acquire A-klinikka Oy, a Finnish provider of substance abuse and addiction treatment services with about 300 employees and contracts across multiple welfare regions and the City of Helsinki. The deal strengthens Atten...
Attendo to Webcast First-Quarter 2026 Results for Investors
Apr 22, 2026
Attendo AB, the leading Nordic provider of social and healthcare services with around 770 units and 33,000 employees in Finland, Sweden and Denmark, continues to position itself as a key private player in addressing regional care challenges. The N...
Attendo Advances SEK 200m Share Buyback, Lifts Treasury Share Holding
Apr 21, 2026
Attendo AB has continued its ongoing share buyback programme, repurchasing 225,000 shares on Nasdaq Stockholm during the week of 13–17 April 2026 for a total of about SEK 24.2 million. The transactions, executed by DNB Carnegie Investment Ba...
Attendo Corrects Notice on Share Buybacks and Confirms Scope of Treasury Purchases
Apr 8, 2026
Attendo AB corrected an earlier disclosure and confirmed that it repurchased 175,000 of its own shares between 30 March and 3 April 2026 under a share buyback programme of up to SEK 200 million. The purchases, executed on Nasdaq Stockholm by DNB C...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.